Home
Watchlist
News
Signals
Picks
DJI
-0.40%
SPX
-0.07%
IXIC
+0.16%
FTSE
-0.46%
N225
+0.39%
AXJO
+0.04%
Log In
Get Started
Home
Watchlist
News
Signals
Picks
Stocks
Add to Watchlist
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.
Company
About Us
Careers
Blog
News
Help & Support
Help Center
Contact Us
Pro Support
Legal
Privacy Policy
Terms of Use
Instagram
YouTube
© 2024 Cashu PTY LTD.
Join our newsletter to keep up to date with us!
Sign Up
Signals
BMRN
Biomarin Pharmaceutical
21 days ago
Analysts think BMRN stock price could increase by 71%
-3.71%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
about 1 month ago
BMRN Erin Burkhart sells $106K worth of shares
0.00%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
about 2 months ago
BMRN beat EPS expectations by 31.47%
0.00%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
3 months ago
Analysts think BMRN stock price could increase by 42%
-7.73%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
3 months ago
BMRN Erin Burkhart sells $93K worth of shares
0.00%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
4 months ago
BMRN Charles Greg Guyer sells $501K worth of shares
0.00%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
4 months ago
BMRN Erin Burkhart sells $92K worth of shares
0.45%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
4 months ago
BMRN beat EPS expectations by 18.43%
0.39%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
5 months ago
Analysts think BMRN stock price could increase by 52%
12.21%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
6 months ago
BMRN has been granted a new patent
-6.66%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
6 months ago
BMRN has been granted a new patent
-6.66%
📡️ Health Care
BMRN
Biomarin Pharmaceutical
6 months ago
BMRN has been granted a new patent
-6.66%
📡️ Health Care
Stocks
Health Care
bmrn
Add to Watchlist
Biomarin Pharmaceutical
BMRN
-0.48 (-0.89%)
54.205
USD
At close at Jun 25, 18:36 UTC
Summary
News
Signals
Benchmarks
Financials